Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation

Breems DA(2005)Prognostic index for adult patients with acute myeloid leukemia in first relapse J Clin Oncol 23 1969-1978

Van Putten WL(2012)Cytoreductive treatment with clofarabine/Ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome Eur J Hematol 88 52-60

Huijgens PC(2011)Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia Leukemia 25 808-813

Ossenkoppele GJ(2010)Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet Blood 115 453-474

Verhoef GE(2010)Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure J Clin Oncol 28 3730-3738

Verdonck LF(1988)A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1141-1154

Buchholz S(2013)Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia Ann Hematol 92 1397-1403

Dammann E(1999)Acute myeloid leukemia N Engl J Med 341 1051-1062

Stadler M(2003)Reduced intensity conditioning and prophylactic DLI can cure patients with high-risk acute leukaemias if complete donor chimerism can be achieved Bone Marrow Transplant 31 339-345

Krauter J(2006)Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up Bone Marrow Transplant 37 45-50

Breems DA(2005)Prognostic index for adult patients with acute myeloid leukemia in first relapse J Clin Oncol 23 1969-1978

Van Putten WL(2012)Cytoreductive treatment with clofarabine/Ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome Eur J Hematol 88 52-60

Huijgens PC(2011)Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia Leukemia 25 808-813

Ossenkoppele GJ(2010)Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet Blood 115 453-474

Verhoef GE(2010)Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure J Clin Oncol 28 3730-3738

Verdonck LF(1988)A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1141-1154

Buchholz S(2013)Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia Ann Hematol 92 1397-1403

Dammann E(1999)Acute myeloid leukemia N Engl J Med 341 1051-1062

Stadler M(2003)Reduced intensity conditioning and prophylactic DLI can cure patients with high-risk acute leukaemias if complete donor chimerism can be achieved Bone Marrow Transplant 31 339-345

Krauter J(2006)Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up Bone Marrow Transplant 37 45-50